Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study

NCT07640048 · clinicaltrials.gov ↗

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma (Icc)

Interventions

DRUG: Adebrelimab
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: S-1
DRUG: Apatinib

Sponsor

Peking Union Medical College Hospital